Biosimilars Role in Improving Patient Access

Today I was on Mark Hansan and Scott Howell’s podcast Prescription for Better Access Podcast on the topic “Biosimilars Role in Improving Patient Access“. The full episode with description is below or you can download the audio-only podcast here. Biosimilars are entering the market at their fastest pace ever. In this episode, we interview a…

Healthcare Economist on Marketplace

What are the economic consequences of the updated USPSTF recommendations to move the age for annual breast cancer screening to age 40? I was interviewed at NPR’s Marketplace Morning Report today (May 11, 2023) to help answer the question. You can listen to the episode here (the segment on breast cancer screening starts at 5:32).…

ISPOR Europe Panels

Mark your calendars and be sure to register: I will be speaking on two panels at the upcoming ISPOR Europe 2021 virtual conference. These panels include: “Addressing Payment Challenges for Alzheimer’s Disease-Modifying Therapies” on December 1, 16:00-17:00 CET and “Challenges in Quantifying the Value of Digital Therapeutics” on December 2, 11:00-12:00 CET. Further event details…

Cigna-Express Scripts merger

Today, Cigna purchased Express Scripts for $52 billion.  This follows another mega-deal where CVS bought Aetna.  The integration of pharmacy benefit managers (PBMs) and insurers is nothing new.  Previously, many insurers managed their own pharmacy benefit.  However, as PBMs grew in size and were able to get larger discounts and rebates, in-house PBMs became less…